)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Standard BioTools (LAB) investor relations material
Standard BioTools Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary4 Nov, 2025
Executive summary
Entered agreement to sell SomaScan Business to Illumina for up to $425M, expected to close in H1 2026, retaining mass cytometry and microfluidics businesses.
Restructuring included consolidating R&D to Singapore, moving HQ to Boston, and a 20% workforce reduction, expected to yield over $40M in annualized cost savings by 2026.
Revenue from continuing operations declined 11% year-over-year for Q3 2025 to $19.6M.
Net loss from continuing operations was $31.7M for Q3 2025.
The company targets positive adjusted EBITDA in 2026, supported by cost savings and a strong cash position.
Financial highlights
Q3 2025 revenue: $19.6M (down from $22.1M in Q3 2024); nine months: $61.5M (down from $66.2M).
Gross margin for Q3 2025 was 48.5%, down from 54.9% in Q3 2024; non-GAAP gross margin was 53.5%.
Operating expenses increased to $42.4M in Q3 2025, up 9% year-over-year, including $9.4M in restructuring charges.
Net loss attributable to common stockholders for Q3 2025 was $34.7M; net loss per share was $0.09.
Cash, cash equivalents, and investments totaled $217.0M as of September 30, 2025.
Outlook and guidance
Management expects the Illumina transaction to close in H1 2026, providing significant liquidity and increasing cash to approximately $550M.
Full-year 2025 combined revenue is expected to be $165–$175M; revenue from continuing operations projected at $78–$83M.
Positive adjusted EBITDA is targeted for 2026, driven by restructuring and operational efficiencies.
Existing liquidity and capital resources are expected to support operations for at least the next 12 months.
Ongoing focus on cost reduction, operational efficiency, and expanding proteomics content.
M&A focus for Illumina cash
Impact of shared costs on 2026 EBITDA target
Strategy for continuing ops revenue growth
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Standard BioTools earnings date
Q4 202527 Feb, 2026
Next Standard BioTools earnings date
Q4 202527 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Standard BioTools Inc. (formerly known as Fluidigm Corporation) is a life sciences technology company that provides advanced tools and systems for biological research. The company specializes in products for mass cytometry, genomics, and other high-throughput techniques that enable researchers to study cell behavior, gene expression, and protein interactions at the molecular level. Standard BioTools' solutions support research in areas such as cancer, immunology, and drug discovery. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage